Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1/2 1

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 82Myelodysplastic Syndromes 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 69Lymphoma, Non-Hodgkin 63Hodgkin Disease 62Leukemia 56Multiple Myeloma 52Lymphoma 46Lymphoma, Follicular 44Lymphoma, Mantle-Cell 41Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Lymphoma, Large B-Cell, Diffuse 40Lymphoma, B-Cell, Marginal Zone 39Myeloproliferative Disorders 36Burkitt Lymphoma 35Congenital Abnormalities 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 27Hematologic Neoplasms 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 22Neoplasms, Plasma Cell 22Leukemia, Myeloid, Accelerated Phase 22Anemia, Refractory, with Excess of Blasts 22Graft vs Host Disease 21Primary Myelofibrosis 20Recurrence 19Leukemia, Prolymphocytic 19Dendritic Cell Sarcoma, Interdigitating 18

Interventions

aldesleukin 22Sunitinib 21Bevacizumab 16Interleukin-2 14Everolimus 14Interferon-alpha 13Gemcitabine 13Cyclophosphamide 13fludarabine phosphate 11Peripheral Blood Stem Cell Transplantation 9Sorafenib 8Filgrastim 8Axitinib 8Nivolumab 7pembrolizumab 6Ipilimumab 6Doxorubicin 6Carboplatin 6sargramostim 5cabozantinib 5Capecitabine 5Thalidomide 4Tacrolimus 4Radiotherapy 4Radiosurgery 4Neoadjuvant Therapy 4Mycophenolic Acid 4Magnetic Resonance Spectroscopy 4Erlotinib Hydrochloride 4Chemotherapy, Adjuvant 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Kidney Neoplasms × Mycophenolic Acid × Clear all
NCT00303719 2020-05-12

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
342 enrolled 14 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Kidney Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT00025519 2013-07-11

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Fox Chase Cancer Center

Phase 2 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00262886 2013-06-06

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

University of Rochester

Phase 2 Completed
35 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00243009 2012-05-28

Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

OHSU Knight Cancer Institute

Phase 2 Terminated
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡